{"entity":{"id":"obi-pharma","kind":"company","name":"OBI Pharma","aka":["OBI Pharma, Inc.","台灣浩鼎","TPEx:4174"],"tldr":"OBI Pharma is a Taiwanese biotech that turns the tumour sugar Globo H into cancer vaccines and antibody-drug conjugates, best known for the breast cancer vaccine adagloxad simolenin.","summary":"OBI Pharma, listed on the Taipei Exchange, develops therapies against Globo-series glycolipids that are over-expressed on many epithelial tumours. Adagloxad simolenin (OBI-822), a Globo H vaccine, is in a phase 3 trial in Globo H-high triple-negative breast cancer. Its pipeline also includes OBI-992, a TROP2 antibody-drug conjugate, and OBI-902, a Globo H-directed conjugate, together with the ThioBridge linker platform.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.obipharma.com/"}],"tags":["drug-maker"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["adagloxad-simolenin","obi-902","obi-992"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo drug-maker linking round (corporate websites and regulatory records)","editedOn":"2026-09-17"},"hq":"Taipei","country":"TW","companyType":"biotech","website":"https://www.obipharma.com/","founded":2002,"stage":"public","investors":[],"funding":[]},"route":"/companies/obi-pharma/","neighbours":{"drug":[{"id":"adagloxad-simolenin","kind":"drug","name":"Adagloxad simolenin","route":"/drugs/adagloxad-simolenin/"},{"id":"obi-902","kind":"drug","name":"OBI-902","route":"/drugs/obi-902/"},{"id":"obi-992","kind":"drug","name":"OBI-992","route":"/drugs/obi-992/"}]}}